日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nine areas with outstanding challenges for hemophilia B research

血友病B研究面临的九个突出挑战领域

Astermark, Jan; Hermans, Cédric; Lenting, Peter J; O'Donnell, James S

Investigation of the Suitability of the ROTEM Assay to Measure Coagulation Potential in Blood From Patients on Concizumab Prophylaxis

研究 ROTEM 检测方法是否适用于测量接受 Concizumab 预防治疗患者血液中的凝血潜能

Eichler, Hermann; Butta, Nora V; Riddell, Anne; Augustsson, Cecilia; Kjalke, Marianne; Jensen, Kasper; Paramo-Florencio, Andrea; Astermark, Jan; Chowdary, Pratima; Jiménez-Yuste, Victor

florio HAEMO-A Digital Medical Device for Monitoring of Treatment, Symptoms and Physical Activities for People Living With Haemophilia

florio HAEMO-A 是一款用于监测血友病患者治疗、症状和身体活动的数字医疗设备

Königs, Christoph; Astermark, Jan; Blatny, Jan; O Hara, Jamie; Iorio, Allfonso; Negrier, Claude; Peyvandi, Flora; Steinitz, Katharina; Reininger, Armin J; Bonanad, Santiago

Haemophilia B: an illustrative review of current challenges and opportunities

乙型血友病:当前挑战与机遇概览

Hermans, Cedric; Astermark, Jan; Trakymienė, Sonata Šaulytė; Jiménez-Yuste, Víctor

Evaluation of One-Stage Assays for the Monitoring of Recombinant Human Factor IX Padua Activity After Etranacogene Dezaparvovec Gene Therapy

评估用于监测 Etranacogene Dezaparvovec 基因治疗后重组人凝血因子 IX Padua 活性的单阶段检测方法

Astermark, Jan; Miesbach, Wolfgang; Coppens, Michiel; Gielen, Sander; Twisk, Jaap; Dolmetsch, Ricardo; Verweij, Stephanie; Monahan, Paul E; Ewenstein, Bruce M; Nuthalapati, Silpa; Galante, Nick; Young, Guy

Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries-Comparisons to Matched Controls

北欧三国血友病男性和女性的合并症和死亡率——与匹配对照组的比较

Steen Carlsson, Katarina; Astermark, Jan; Baghaei, Fariba; Brodin, Elisabeth; Funding, Eva; Holmström, Margareta; Österholm, Klaus; Bergenstråle, Sofia; Lethagen, Stefan

Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)

北欧中度血友病A和B患者体内的非中和抗体(MoHem研究)

Måseide, Ragnhild J; Berntorp, Erik; Astermark, Jan; Olsson, Anna; Bruzelius, Maria; Frisk, Tony; Nummi, Vuokko; Lassila, Riitta; Strandberg, Karin; Tjønnfjord, Geir E; Holme, Pål A

Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions

未来血友病领域持续创新的需求:改善所有严重程度患者的治疗效果,包括女性患者和资源匮乏地区的患者。

Blatný, Jan; Astermark, Jan; Catarino, Cristina; Dolan, Gerry; Fijnvandraat, Karin; Hermans, Cédric; Holstein, Katharina; Jiménez-Yuste, Víctor; Klamroth, Robert; Lavin, Michelle; Lenting, Peter J; Lobet, Sébastien; Mancuso, Maria Elisa; Motwani, Jayashree; O'Donnell, James S; Königs, Christoph

The IgG-degrading enzyme, Imlifidase, restores the therapeutic activity of FVIII in inhibitor-positive hemophilia A mice

IgG降解酶Imlifidase可恢复抑制剂阳性A型血友病小鼠体内FVIII的治疗活性。

Bou-Jaoudeh, Melissa; Delignat, Sandrine; Daventure, Victoria; Astermark, Jan; Lévesque, Hervé; Dimitrov, Jordan D; Deligne, Claire; Proulle, Valérie; Lacroix-Desmazes, Sébastien

High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study

血友病患者大量使用止痛药、抗抑郁药和抗焦虑药:一项为期11年的北欧登记研究纳入了3000多名血友病患者。

Steen Carlsson, Katarina; Winding, Bent; Astermark, Jan; Baghaei, Fariba; Brodin, Elisabeth; Funding, Eva; Holmström, Margareta; Österholm, Klaus; Bergenstråle, Sofia; Lethagen, Stefan